Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets.

Cell reports - 17 Oct 2013

Zaman Naif, Li Lei, Jaramillo Maria Luz, Sun Zhanpeng, Tibiche Chabane, Banville Myriam, Collins Catherine, Trifiro Mark, Paliouras Miltiadis, Nantel Andre, O'Connor-McCourt Maureen, Wang Edwin

Abstract excerpt

Individual cancer cells carry a bewildering number of distinct genomic alterations (e.g., copy number variations and mutations), making it a challenge to uncover genomic-driven mechanisms governing tumorigenesis. Here, we performed exome sequencing on several breast cancer cell lines that represe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Molecular Targeted Therapy

Share to Mutation

Share to Signal Transduction

Source

Identifiers

PMID: 24075989
DOI: 10.1016/j.celrep.2013.08.028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24075989-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets.PMID 24075989Read ↗

Identification of significantly mutated subnetworks in the breast cancer genome.Semantic proximity Read ↗

Exome analysis reveals differentially mutated gene signatures of stage, grade and subtype in breast cancers.Semantic proximity Read ↗

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene DiscoverySemantic proximity Read ↗

Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast CancerSemantic proximity Read ↗

Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune ActivitySemantic proximity Read ↗

An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.Semantic proximity Read ↗

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.Semantic proximity Read ↗

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines.Semantic proximity Read ↗

Integrating genetic and gene expression data in network-based stratification analysis of cancersSemantic proximity Read ↗

Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis.Semantic proximity Read ↗

A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Semantic proximity Read ↗

Decoding molecular signatures and identifying therapeutic targets in triple-negative breast cancer subtypes using omics and network analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.